Skip to main content
Clinical Trials/NCT02777346
NCT02777346
Completed
Not Applicable

Evaluation of Emergency Suturing With Absorbable Versus Non-absorbable Suture Material in a Pediatric Population

Pediatric Clinical Research Platform1 site in 1 country550 target enrollmentMay 1, 2016

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Wounds and Injuries
Sponsor
Pediatric Clinical Research Platform
Enrollment
550
Locations
1
Primary Endpoint
Short-term infection risk
Status
Completed
Last Updated
10 months ago

Overview

Brief Summary

The investigators recruit patients admitted to the Pediatric Emergency Department of the Geneva's University Hospital with open wounds needing suture. The patients are treated with absorbable versus non-absorbable suture material according to randomization.

Outcomes are:

  1. infection rate at the first follow-up (between 4 and 14 days, depending on the sutured site and defined by protocol)
  2. scar appearance at a 6-months follow-up.

Detailed Description

The investigators recruit patients admitted to the Pediatric Emergency Department of the Geneva's University Hospital with open wounds needing suture. The patients are treated with absorbable versus non-absorbable suture material according to randomization. After obtaining the patient's/parent's consent and randomization, the suture material will be provided. Selection of the size of the thread and the date of the first follow-up are determined as follows: * Face: Thread size 5-0 to 7-0, first follow-up 4-7 days * Torso/back: Thread size 4-0 or 5-0, first follow-up 10-14 days * Arms: Thread size 4-0 or 5-0, first follow-up 7- 10 days * Hand: Thread size 5-0 or 6-0, first follow-up 7-10 days * Legs: Thread size 4-0 or 5-0, first follow-up 7-14 days The patients are examined by in the outpatient wound clinic by specialised nurses under medical supervision at the first follow-up, and at six months by one of the investigators. Outcomes: 1. infection rate at the first follow-up (between 4 and 14 days, depending on the sutured site and defined by protocol) 2. scar appearance at a 6-months follow-up.

Registry
clinicaltrials.gov
Start Date
May 1, 2016
End Date
February 6, 2025
Last Updated
10 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Pediatric Clinical Research Platform
Responsible Party
Principal Investigator
Principal Investigator

Giorgio La Scala

PD, MD; Attending Surgeon

University Hospital, Geneva

Eligibility Criteria

Inclusion Criteria

  • Patient younger than 16 years of age with a wound requiring suture

Exclusion Criteria

  • Deep wounds with lesions of subcutaneous structures (tendons, nerves, etc.)
  • Wounds with tissue loss
  • Diabetic patients or patients treated with drugs potentially compromising cicatrization (e.g. steroids, immunosuppressors, etc.)
  • Wounds caused by animal or human bites
  • Sutures not performed in the emergency room
  • Heavily soiled wounds

Outcomes

Primary Outcomes

Short-term infection risk

Time Frame: 4 to 21 days

Scars classified as "no evidence of infection", "signs of inflammation" and "signs of active infection"

Secondary Outcomes

  • Scar appearance(6 months)

Study Sites (1)

Loading locations...

Similar Trials